ICM
UTHR icon

ICC Capital Management’s United Therapeutics UTHR Stock Holding History

ICC Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$718K Buy
+4,166
New +$635K 0.09% 205

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

ICC Capital Management's UTHR Position: Q1 2015 in Review

ICC Capital Management opened a new position in United Therapeutics (UTHR) in Q1 2015: 4,166 shares worth $718K. The stake represents 0.09% of the portfolio and ranks #205 among its holdings.

367 funds tracked by Wall St. Rank hold UTHR as of Q1 2015.

  • ICC Capital Management held 4,166 shares of United Therapeutics worth $718K as of Q1 2015.
  • United Therapeutics was a new ICC Capital Management position in Q1 2015.
  • United Therapeutics made up 0.09% of ICC Capital Management's portfolio in Q1 2015, its #205 holding.
  • 367 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2015.

Based on ICC Capital Management's 13F filing for Q1 2015, filed 13 May 2015.